MET vs VTAK · P/E 13, rev $38.23B vs rev $1.5M
MetLife Inc (MET) versus Catheter Precision Inc. (VTAK) — a side-by-side from cached financials, not a winner call.
MetLife Inc (MET) is a insurance - life company listed on US.
Catheter Precision Inc. (VTAK) is a medical devices company listed on US.
Latest reported MET revenue for 2026-06-30 was $38.23B. Net income was $1.92B. MET currently screens at market cap $52.16B and trailing P/E 12.7.
Latest reported VTAK revenue for 2026-06-30 was $1.5M. Net income was -$5.0M. VTAK currently screens at market cap $3.0M.
MET currently screens at market cap $52.16B and trailing P/E 12.7. VTAK currently screens at market cap $3.0M.
Not investment advice. Open the MET and VTAK stock pages for the full models.
Not investment advice.